SCIENTURE HOLDINGS, INC. Diluted Shares Outstanding (Weighted Average)
SCIENTURE HOLDINGS, INC. (SCNX) reported Diluted Shares Outstanding (Weighted Average) of 39.62 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 39.62M shares, a 180.14% increase year-over-year.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 40.63M shares, a 331.06% increase year-over-year.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 18.58M shares, a 107.69% increase year-over-year.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 18.96M shares, a 698.60% increase year-over-year.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 15.35M shares, a 320.06% increase from fiscal 2024.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 3.65M shares, a 53.42% increase from fiscal 2023.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 2.38M shares, a 320.30% increase from fiscal 2022.
- SCIENTURE HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 566.61K shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 39.62M shares 10-Q · filed 2026-08-13 | 39.62M shares 10-Q · filed 2026-08-13 | 32.94M shares derived: average of 3 quarters · filed 2026-08-13 | 29.45M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 40.63M shares 10-Q · filed 2026-05-15 | 29.61M shares derived: average of 2 quarters · filed 2026-05-15 | 26.06M shares derived: average of 3 quarters · filed 2026-05-15 | 23.08M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 18.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 18.77M shares derived: average of 2 quarters · filed 2026-03-30 | 17.23M shares derived: average of 3 quarters · filed 2026-08-13 | 15.35M shares 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | 18.96M shares 10-Q · filed 2025-11-12 | 16.55M shares derived: average of 2 quarters · filed 2026-08-13 | 14.27M shares 10-Q · filed 2025-11-12 | 12.87M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 14.14M shares 10-Q · filed 2026-08-13 | 11.84M shares 10-Q · filed 2026-08-13 | 10.84M shares derived: average of 3 quarters · filed 2026-08-13 | 8.72M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 9.43M shares 10-Q · filed 2026-05-15 | 9.19M shares derived: average of 2 quarters · filed 2026-05-15 | 6.92M shares derived: average of 3 quarters · filed 2026-05-15 | 5.54M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 8.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 5.66M shares derived: average of 2 quarters · filed 2026-03-30 | 4.24M shares derived: average of 3 quarters · filed 2026-03-30 | 3.65M shares 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | 2.37M shares 10-Q · filed 2025-11-12 | 1.89M shares derived: average of 2 quarters · filed 2025-11-12 | 1.89M shares 10-Q · filed 2025-11-12 | 1.92M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 1.41M shares 10-Q · filed 2025-08-12 | 1.45M shares 10-Q · filed 2025-08-12 | 1.77M shares derived: average of 3 quarters · filed 2025-08-12 | 1.92M shares derived: average of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | 1.27M shares 10-Q · filed 2025-05-12 | 1.95M shares derived: average of 2 quarters · filed 2025-05-12 | 2.09M shares derived: average of 3 quarters · filed 2025-05-12 | 1.73M shares derived: average of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | 2.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 2.49M shares derived: average of 2 quarters · filed 2025-03-26 | 1.89M shares derived: average of 3 quarters · filed 2025-03-26 | 2.38M shares 10-K · filed 2025-03-26 | ||||
| 2023-09-30 | 2.36M shares 10-Q · filed 2024-11-06 | 1.52M shares derived: average of 2 quarters · filed 2024-11-06 | 2.30M shares 10-Q · filed 2024-11-06 | 1.08M shares derived: average of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | 681.20K shares 10-Q · filed 2024-08-09 | 675.14K shares 10-Q · filed 2024-08-09 | 657.49K shares derived: average of 3 quarters · filed 2024-08-09 | 631.05K shares derived: average of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | 670.72K shares 10-Q · filed 2024-06-26 | 645.64K shares derived: average of 2 quarters · filed 2024-06-26 | 614.33K shares derived: average of 3 quarters · filed 2024-06-26 | 597.10K shares derived: average of 4 quarters · filed 2024-06-26 | ||||
| 2022-12-31 | 620.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | 586.14K shares derived: average of 2 quarters · filed 2024-04-22 | 572.56K shares derived: average of 3 quarters · filed 2024-04-22 | 566.61K shares 10-K · filed 2024-04-22 | ||||
| 2022-09-30 | 551.72K shares 10-Q · filed 2024-01-16 | 548.56K shares derived: average of 2 quarters · filed 2024-01-16 | 548.63K shares 10-Q · filed 2024-01-16 | |||||
| 2022-06-30 | 545.40K shares 10-Q · filed 2023-08-18 | 545.31K shares 10-Q · filed 2023-08-18 | ||||||
| 2021-09-30 | 8.16M shares 10-Q · filed 2021-10-25 | 8.14M shares derived: average of 2 quarters · filed 2021-10-25 | 8.13M shares 10-Q · filed 2021-10-25 | |||||
| 2021-06-30 | 8.12M shares 10-Q · filed 2021-07-26 | 8.11M shares 10-Q · filed 2021-07-26 | ||||||
| 2021-03-31 | 8.09M shares 10-Q · filed 2021-04-26 | |||||||
| 2020-09-30 | 8.06M shares 10-Q · filed 2021-10-25 | 8.22M shares 10-Q · filed 2020-10-26 | 7.82M shares derived: average of 2 quarters · filed 2021-10-25 | 7.57M shares 10-Q · filed 2021-10-25 | 7.73M shares 10-Q · filed 2020-10-26 | 7.18M shares derived: average of 4 quarters · filed 2021-10-25 | ||
| 2020-06-30 | 7.58M shares 10-Q · filed 2021-07-26 | 7.32M shares 10-Q · filed 2021-07-26 | 6.88M shares derived: average of 3 quarters · filed 2021-07-26 | 6.67M shares derived: average of 4 quarters · filed 2021-07-26 | ||||
| 2020-03-31 | 7.42M shares 10-Q · filed 2021-04-26 | 6.53M shares derived: average of 2 quarters · filed 2021-04-26 | 6.37M shares derived: average of 3 quarters · filed 2021-04-26 | 6.29M shares derived: average of 4 quarters · filed 2021-04-26 | ||||
| 2019-12-31 | 5.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 5.84M shares derived: average of 2 quarters · filed 2020-10-26 | 5.91M shares derived: average of 3 quarters · filed 2020-10-26 | 5.93M shares 10-K · filed 2020-03-30 | ||||
| 2019-09-30 | 6.05M shares 10-Q · filed 2020-10-26 | 36.29M shares 10-Q · filed 2019-10-28 | 6.05M shares derived: average of 2 quarters · filed 2020-10-26 | 6.03M shares 10-Q · filed 2020-10-26 | 36.17M shares 10-Q · filed 2019-10-28 | -15.70M shares derived: average of 4 quarters · filed 2020-10-26 | ||
| 2019-06-30 | 6.06M shares 10-Q · filed 2020-07-27 | 36.35M shares 10-Q · filed 2019-07-26 | 6.06M shares 10-Q · filed 2020-07-27 | 36.35M shares 10-Q · filed 2019-07-26 | -22.94M shares derived: average of 3 quarters · filed 2020-07-27 | -8.52M shares derived: average of 4 quarters · filed 2020-07-27 | ||
| 2019-03-31 | 6.00M shares 10-Q · filed 2020-05-04 | 35.99M shares 10-Q · filed 2019-05-13 | -37.45M shares derived: average of 2 quarters · filed 2020-05-04 | -13.39M shares derived: average of 3 quarters · filed 2020-05-04 | -1.42M shares derived: average of 4 quarters · filed 2020-05-04 | |||
| 2018-12-31 | -80.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -23.08M shares derived: average of 2 quarters · filed 2020-03-30 | -3.89M shares derived: average of 3 quarters · filed 2020-03-30 | 5.83M shares 10-K · filed 2020-03-30 | 34.96M shares 10-K · filed 2019-03-22 | |||
| 2018-09-30 | 34.74M shares 10-Q · filed 2019-10-28 | 34.61M shares derived: average of 2 quarters · filed 2019-10-28 | 34.73M shares 10-Q · filed 2019-10-28 | 34.35M shares derived: average of 4 quarters · filed 2019-10-28 | ||||
| 2018-06-30 | 34.48M shares 10-Q · filed 2019-07-26 | 34.47M shares 10-Q · filed 2019-07-26 | 34.22M shares derived: average of 3 quarters · filed 2019-07-26 | 34.18M shares derived: average of 4 quarters · filed 2019-07-26 | ||||
| 2018-03-31 | 34.06M shares 10-Q · filed 2019-05-13 | 34.09M shares derived: average of 2 quarters · filed 2019-05-13 | 34.09M shares derived: average of 3 quarters · filed 2019-05-13 | 33.56M shares derived: average of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | 34.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | 34.10M shares derived: average of 2 quarters · filed 2019-03-22 | 33.39M shares derived: average of 3 quarters · filed 2019-03-22 | 34.09M shares 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | 34.08M shares 10-Q · filed 2018-10-26 | 33.03M shares derived: average of 2 quarters · filed 2018-10-26 | 34.08M shares 10-Q · filed 2018-10-26 | 33.00M shares derived: average of 4 quarters · filed 2018-10-26 | ||||
| 2017-06-30 | 31.99M shares 10-Q · filed 2018-07-27 | 34.06M shares 10-Q · filed 2018-07-27 | 32.64M shares derived: average of 3 quarters · filed 2018-07-27 | 32.38M shares derived: average of 4 quarters · filed 2018-07-27 | ||||
| 2017-03-31 | 34.26M shares 10-Q · filed 2018-04-27 | 32.96M shares derived: average of 2 quarters · filed 2018-04-27 | 32.51M shares derived: average of 3 quarters · filed 2018-04-27 | 32.25M shares derived: average of 4 quarters · filed 2018-04-27 | ||||
| 2016-12-31 | 31.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | 31.64M shares derived: average of 2 quarters · filed 2018-03-02 | 31.58M shares derived: average of 3 quarters · filed 2018-03-02 | 31.54M shares 10-K · filed 2018-03-02 | ||||
| 2016-09-30 | 31.61M shares 10-Q · filed 2017-11-07 | 31.54M shares derived: average of 2 quarters · filed 2017-11-07 | 31.51M shares 10-Q · filed 2017-11-07 | 31.49M shares derived: average of 4 quarters · filed 2017-11-07 | ||||
| 2016-06-30 | 31.47M shares 10-Q · filed 2017-08-04 | 31.47M shares 10-Q · filed 2016-08-05 | 31.47M shares 10-Q · filed 2017-08-04 | 31.45M shares derived: average of 3 quarters · filed 2017-08-04 | 31.41M shares derived: average of 4 quarters · filed 2017-08-04 | |||
| 2016-03-31 | 31.44M shares 10-Q · filed 2017-05-15 | 31.45M shares derived: average of 2 quarters · filed 2017-05-15 | 31.39M shares derived: average of 3 quarters · filed 2017-05-15 | 31.36M shares derived: average of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | 31.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | 31.36M shares derived: average of 2 quarters · filed 2016-11-14 | 31.33M shares derived: average of 3 quarters · filed 2016-11-14 | 31.32M shares 10-K · filed 2016-03-28 | ||||
| 2015-09-30 | 31.27M shares 10-Q · filed 2016-11-14 | 31.27M shares derived: average of 2 quarters · filed 2016-11-14 | 31.27M shares 10-Q · filed 2016-11-14 | 31.24M shares derived: average of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | 31.27M shares 10-Q · filed 2016-08-05 | 31.27M shares 10-Q · filed 2016-08-05 | 31.24M shares derived: average of 3 quarters · filed 2016-08-05 | 30.83M shares derived: average of 4 quarters · filed 2016-08-05 | ||||
| 2015-03-31 | 31.27M shares 10-Q · filed 2016-04-20 | 31.22M shares derived: average of 2 quarters · filed 2016-04-20 | 30.68M shares derived: average of 3 quarters · filed 2016-04-20 | 30.36M shares derived: average of 4 quarters · filed 2016-04-20 | ||||
| 2014-12-31 | 31.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | 30.38M shares derived: average of 2 quarters · filed 2016-03-28 | 30.06M shares derived: average of 3 quarters · filed 2016-03-28 | 29.83M shares 10-K · filed 2016-03-28 | ||||
| 2014-09-30 | 29.60M shares 10-Q · filed 2015-11-02 | 29.51M shares derived: average of 2 quarters · filed 2015-11-02 | 29.39M shares 10-Q · filed 2015-11-02 | 29.19M shares derived: average of 4 quarters · filed 2015-11-02 | ||||
| 2014-06-30 | 29.42M shares 10-Q · filed 2015-07-30 | 29.42M shares 10-Q · filed 2015-07-30 | 29.28M shares 10-Q · filed 2014-08-21 | 29.06M shares derived: average of 3 quarters · filed 2015-07-30 | 28.66M shares derived: average of 4 quarters · filed 2015-07-30 | |||
| 2014-03-31 | 29.13M shares 10-Q · filed 2015-05-04 | 28.87M shares derived: average of 2 quarters · filed 2015-05-04 | 28.41M shares derived: average of 3 quarters · filed 2015-05-04 | 21.31M shares derived: average of 4 quarters · filed 2015-05-04 | ||||
| 2013-12-31 | 28.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | 28.05M shares derived: average of 2 quarters · filed 2015-03-23 | 18.70M shares derived: average of 3 quarters · filed 2015-03-23 | 14.10M shares 10-K · filed 2015-03-23 | ||||
| 2013-09-30 | 27.49M shares 10-Q · filed 2014-10-30 | 13.74M shares derived: average of 2 quarters · filed 2014-10-30 | 9.26M shares 10-Q · filed 2014-10-30 | |||||
| 2013-06-30 | 0.00 shares 10-Q · filed 2014-08-21 | 0.00 shares 10-Q · filed 2014-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |